Home / United States / Veraxa Biotech AG Ordinary Sha (VRXA)
Veraxa Biotech AG Ordinary Sha (VRXA)
Short position disclosed on August 31, 2026.
FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | Shares sold short | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 202,960 shares | -37,594 shares | August 31, 2026 |
Get the moves on Veraxa Biotech AG Ordinary Sha (VRXA) by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | Shares sold short | End of publication |
|---|---|---|---|
| August 31, 2026 | Aggregated total | 202,960 shares | still open |
| August 14, 2026 | Aggregated total | 378,219 shares | |
| July 31, 2026 | Aggregated total | 399,577 shares | |
| July 15, 2026 | Aggregated total | 240,554 shares |
Download 4 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the United States
- Lucas GC Limited Ordinary Shar (LGCL) 61.62%
- Flash Sports & Media Holdings, (FLZH) 59.16%
- BTC Digital Ltd. Ordinary Shar (BTCT) 47.02%
- Wolfspeed, Inc. (WOLF) 46.50%
- Karyopharm Therapeutics Inc. C (KPTI) 43.27%
- Ondas Inc. Common Stock (ONDS) 39.71%
- Capricor Therapeutics, Inc. Co (CAPR) 38.16%
- Hertz Global Holdings, Inc Com (HTZ) 36.25%
- TruGolf Holdings, Inc. Class A (TRUG) 36.10%
- Serve Robotics Inc. Common Sto (SERV) 35.35%
- Nexera Technologies Ltd Ordina (NEXR) 35.00%
- LENZ Therapeutics, Inc. Common (LENZ) 34.61%
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Veraxa Biotech AG Ordinary Sha (VRXA), source FINRA, data as at August 31, 2026, https://www.quivad.com/action/veraxa-biotech-ag-ordinary-sha-vrxa